Molecular mechanism of compound anisodine in improving ischemic ophthalmopathy by regulating AMPK/mTOR pathway

Weijie Yang; Jing Chen; Zhengrong Shen; Hong Xu

doi:10.1016/j.jrras.2026.102397

Citations

391

Views

Abstract not available for this publication.

Cite this Article (APA)

Weijie, Y., Jing, C., Zhengrong, S., Hong, X. (2026). Molecular mechanism of compound anisodine in improving ischemic ophthalmopathy by regulating AMPK/mTOR pathway. Journal of Radiation Research and Applied Sciences. https://doi.org/10.1016/j.jrras.2026.102397

Jun Zhang; Bassant Elkalzah; Yunan Liu; A. Almutairi · 2026

cites

390

Analysis of photon shielding properties and buildup factors of epoxy composites reinforced with tita…

Nermeen S. Gaballah; Mona M. Gouda; Dina G. Yakot; Walaa M.R. Alahmade; Abdallah · 2026

cites

392

Robust estimation of mean under probability proportional to size sampling: An application to radiati…

Anis Ben Ghorbal · 2026

cites

391

Bayesian and non-Bayesian inference for the inverse power induced XLindley distribution with applica…